Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2026-01-14 @ 5:39 PM
Study NCT ID:
NCT01780233
Status:
COMPLETED
Last Update Posted:
2013-01-31
First Post:
2013-01-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetic Study of Fentanyl 400 µg Sublingual Spray, Actiq® 400 µg Transmucosally, and Fentanyl Citrate Injection 100 µg Intravenously (iv)
Sponsor:
INSYS Therapeutics Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-04
Start Date Type:
None
Primary Completion Date:
2007-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-05
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-28
First Submit QC Date:
None
Study First Post Date:
2013-01-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-01-28
Last Update Post Date:
2013-01-31
Last Update Post Date Type:
ESTIMATED